Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Convertible Debt of $238.5 million for Q1 2026, little changed year-over-year from $237.4 million in Q1 2025, and little changed quarter-over-quarter from $238.2 million in Q4 2025.
Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2026) Analysis & Trends
Collegium Pharmaceutical's Convertible Debt history runs 7 years deep, the most recent figure standing at $238.5 million for Q1 2026.
- In Q1 2026, Convertible Debt changed 0.44% year-over-year to $238.5 million; the TTM figure through Mar 2026 stood at $238.5 million (changed 0.44% YoY), while the FY2025 annual figure was $238.2 million, changed 0.44% from the prior year.
- Convertible Debt for Q1 2026 stood at $238.5 million, roughly flat from $238.2 million in the prior quarter.
- The five-year high for Convertible Debt was $262.4 million in Q1 2024, with the low at $26.4 million in Q1 2022.
- The 5-year median for Convertible Debt is $237.7 million (2025), against an average of $215.2 million.
- The sharpest annual moves came in 2022 and 2023: Convertible Debt tumbled 81.08% in 2022, then surged 891.35% in 2023.
- Collegium Pharmaceutical's Convertible Debt stood at $140.9 million in 2022, then surged by 86.07% to $262.1 million in 2023, then slipped by 9.52% to $237.2 million in 2024, then increased by 0.44% to $238.2 million in 2025, then rose by 0.11% to $238.5 million in 2026.
- Business Quant data shows COLL's Convertible Debt at $238.5 million in Q1 2026, $238.2 million in Q4 2025, and $238.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Collegium Pharmaceutical | 889.43 Mn | 740.11 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 238.73 Mn |
| Mar 31, 2026 | 238.47 Mn |
| Dec 31, 2025 | 238.21 Mn |
| Sep 30, 2025 | 237.95 Mn |
| Jun 30, 2025 | 237.69 Mn |
| Mar 31, 2025 | 237.43 Mn |
| Dec 31, 2024 | 237.17 Mn |
| Sep 30, 2024 | 236.91 Mn |
| Jun 30, 2024 | 236.65 Mn |
| Mar 31, 2024 | 262.43 Mn |
| Dec 31, 2023 | 262.13 Mn |
| Sep 30, 2023 | 261.82 Mn |
| Jun 30, 2023 | 261.52 Mn |
| Mar 31, 2023 | 261.22 Mn |
| Dec 31, 2022 | 140.87 Mn |
| Sep 30, 2022 | 140.64 Mn |
| Jun 30, 2022 | 140.42 Mn |
| Mar 31, 2022 | 26.35 Mn |
| Dec 31, 2021 | 139.97 Mn |
| Sep 30, 2021 | 139.74 Mn |